Comparison of Tumor Control and Toxicity Outcomes of High Dose Intensity-Modulated Radiotherapy and Brachytherapy for Patients with Favorable Risk Prostate Cancer

OBJECTIVES: To compare long-term prostate-specific antigen relapse-free survival outcome and incidence of toxicity for low-risk prostate cancer treated with brachytherapy or intensity-modulated radiotherapy. METHODS: 729 consecutive patients were treated with BRT (n=448; prescription dose, 144 Gy) a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zelefsky, Michael J., Yamada, Yoshiya, Pei, Xin, Hunt, Margie, Cohen, Gilad, Zhang, Zhigang, Zaider, Marco
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4037156/
https://ncbi.nlm.nih.gov/pubmed/21195465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2010.07.539
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak